Fortune Mate Indonesia Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Fortune Mate Indonesia Tbk trades at Rp252 (market cap 1.59T, 142.4K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Fortune Mate Indonesia Tbk is far larger — about 2.2× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 142.4K). Which is the better fit depends on your goals.
| FMII | RSCH | |
|---|---|---|
Market Cap | 1.59T | 715.5B |
Volume | 142.4K | 30.64M |
Lot | 1.42K | 306.41K |
Turnover | 35.31M | 7.98B |
Average Price | 247.99 | 260.34 |
Value | 35.31M | 7.98B |
Indicative Equilibrium Price | 252 | 256 |
Indicative Equilibrium Volume | 33 | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Read more on FMII →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →